| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |